Publication:
Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics.

dc.contributor.authorMartínez-Ortega, Antonio
dc.contributor.authorFlores-Martinez, Álvaro
dc.contributor.authorVenegas-Moreno, Eva
dc.contributor.authorDios, Elena
dc.contributor.authorDel Can, Diego
dc.contributor.authorRivas, Eloy
dc.contributor.authorKaen, Ariel
dc.contributor.authorCárdenas Ruiz-Valdepeñas, Eugenio
dc.contributor.authorFajardo, Elena
dc.contributor.authorRoldán, Florinda
dc.contributor.authorGonzález-Rivera, Natividad
dc.contributor.authorOliva, Rosario
dc.contributor.authorFernández-Peña, José Ignacio
dc.contributor.authorSoto-Moreno, Alfonso
dc.contributor.authorCano, David A
dc.date.accessioned2023-05-03T14:04:30Z
dc.date.available2023-05-03T14:04:30Z
dc.date.issued2022-01-05
dc.description.abstractCraniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs express sex hormone receptors, including estrogen and progesterone receptors. Here, we systematically analyzed estrogen receptor α (ERα) and progesterone receptor (PR) expression by immunohistochemistry in a well-characterized series of patients with CP (n = 41) and analyzed their potential association with tumor aggressiveness features. A substantial proportion of CPs displayed a marked expression of PR. However, most CPs expressed low levels of ERα. No major association between PR and ERα expression and clinical aggressiveness features was observed in CPs. Additionally, in our series, β-catenin accumulation was not related to tumor recurrence.
dc.identifier.doi10.3390/jcm11010281
dc.identifier.issn2077-0383
dc.identifier.pmcPMC8746083
dc.identifier.pmid35012020
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746083/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2077-0383/11/1/281/pdf?version=1641534089
dc.identifier.urihttp://hdl.handle.net/10668/21228
dc.issue.number1
dc.journal.titleJournal of clinical medicine
dc.journal.titleabbreviationJ Clin Med
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationAGS - Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectcraniopharyngiomas
dc.subjectestrogen receptor
dc.subjectimmunohistochemistry
dc.subjectprogesterone receptor
dc.subjectβ-catenin
dc.titleSex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8746083.pdf
Size:
14.63 MB
Format:
Adobe Portable Document Format